BON.F Boiron SA

Healthcare Pharmaceuticals Frankfurt Exchange
18.82 EUR
Close of Nov 12, 2026
16.50 29.82
Market cap
EUR 327M
P/E
11.9x
P/B
0.90x
ROE
8.3%
Dividend yield
6.38%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is BON.F undervalued?

Graham number
Price18.82
Graham value27.20
Discount30.8%

BON.F trades 30.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Boiron SA fundamental analysis

No fundamental analysis for Boiron SA yet.

Boiron SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Boiron SA

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and ac…

Full company profile